von Tobias Borgers | Mrz 21, 2024 | Continuous Manufacturing
Patient safety is an Industry 4.0 technology driver, by aggregating real-time data and transfer it to a centralised data hub, monitored regularly to protect patients. Blockchain technology can detect product anomalies, and recalls can be done even before the...
von Tobias Borgers | Mrz 21, 2024 | Fachzeitschriften
20 Millionen Euro Investition Neues Technikum stärkt Standort von Covestro in NRW Am 5. März 2024 hat Covestro im Chempark Leverkusen sein neues, hochmodernes Technikum für Hochviskostechnologie eingeweiht. Es soll den Kunststoff-Hersteller künftig dabei unterstützen,...
von Tobias Borgers | Mrz 21, 2024 | Continuous Manufacturing
The pharmaceutical industry is confronting a variety of new and complex challenges in the face of globalization and changing market dynamics. The past decade has witnessed a decline in the discovery, approval and marketing of new chemical entities with fewer...
von Tobias Borgers | Mrz 21, 2024 | Boehringer
Bei der Forschung nach neuen therapeutischen Antikörpern setzt Boehringer Ingelheim auf die Unterstützung durch KI. Foto: Corona Borealis Studio – shutterstock.comUm die Entwicklung neuer Medikamente zu beschleunigen, setzt das 1885 gegründete...
von Tobias Borgers | Feb 23, 2024 | Glaxo
GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of Aiolos Bio (Aiolos), a clinical-stage biopharmaceutical company focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. As previously...
